Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats

This publication has 24 references indexed in Scilit:

• Human tissue-type plasminogen activator: from the laboratory to the bedside.
  Circulation, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• Thrombolytic Therapy
  New England Journal of Medicine, 1984
• Thrombolytic Therapy
  New England Journal of Medicine, 1984
• The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion.
  Circulation, 1984
• Thrombolysis, clot selectivity, and kinetics.
  Circulation, 1984
• Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.
  Circulation, 1984
• Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen Activator
  Science, 1983
• Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATION
  Journal of Clinical Investigation, 1983
• The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.
  Circulation, 1978